BCPP study materials
BCPP study resources

BCPP: Professional Practice, Interprofessional Collaboration, and Practice Management

BCPP · Work through your exam, one topic at a time.

All guide sections

Professional Practice, Interprofessional Collaboration, and Practice Management

Scope, agreements, and documentation

Psychiatric pharmacists practice through collaborative practice agreements (CPAs) that define prescriptive authority, protocols, and monitoring parameters under state law. Know the difference between consultation, collaborative drug therapy management, and independent prescribing. Documentation should be problem-oriented and measurement-based (SOAP format, rating scale scores, labs, adherence data) so that a collaborating prescriber can act on it without re-interviewing the patient.

Confidentiality and consent

HIPAA governs general protected health information, but substance use disorder records are additionally protected under 42 CFR Part 2, which restricts redisclosure even with a general medical release. Informed consent requires capacity, disclosure of risks and alternatives, and voluntariness. Know the duty to warn/protect framework (Tarasoff-type obligations), involuntary hold criteria in your jurisdiction, and the limits of confidentiality when imminent risk exists.

Controlled substances

Buprenorphine no longer requires a separate DATA-2000 waiver, but practitioners still need a standard DEA registration with the appropriate schedule authority and must meet the one-time training requirement. Clozapine, isotretinoin, and long-acting injectable naltrexone fall under REMS or restricted distribution programs; medication reconciliation at transitions of care prevents duplication and omission.

Teamwork and de-escalation

Interprofessional practice means clear role delineation with psychiatry, nursing, primary care, social work, and pharmacy technicians. The collaborative care model uses a registry, measurement-based treatment targets, and weekly caseload review. Verbal de-escalation precedes pharmacologic restraint; document the least restrictive option tried.

Rule of thumb

Before recommending any therapy change, ask whether the plan is within your scope, documented, and communicated to the prescriber in a format they can act on.